HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

317.484

-1.962-0.61%

Number of Gainers:13

Number of Losers:34

Number of Flat:12

PE:- -

High:319.886

Open:319.429

Low:313.595

Close:319.447

Volume:104.60M

Turnover:3.56B

Market Cap:752.35B

Float Cap:670.18B

Loading ...

BetterLife Holding H1 Revenue RMB 3,852.6 Million

THOMSON REUTERS

BetterLife Holding Ltd - Board Proposed not to Declare Any Interim Dividend

THOMSON REUTERS

BetterLife Turns to H1 FY26 Net Loss of RMB 107.3 Million; Revenue Rises 1% to RMB 3.85 Billion

China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth

Shanghai HeartCare Medical Technology - Board Did not Declare the Payment of an Interim Dividend

THOMSON REUTERS

Shanghai HeartCare H1 FY26 Profit Climbs 18.5% to RMB 60.37 Million; Revenue Rises 56.9% to RMB 291.03 Million

Shanghai HeartCare Medical Technology H1 Revenue RMB 291 Million

THOMSON REUTERS

Hong Kong Stocks Edge Lower on Monday Amid Middle East Tensions; HUTCHMED Falls 2%

MT Newswires Live

Hutchmed Says Savolitinib Plus AstraZeneca’s Tagrisso Extends PFS in China Phase III Sanovo Lung Cancer Trial

Rebuilding Foundations: How KANGQIAO SER Charts a Quality-Driven Path in a Shifting Property Market

Hong Kong Stock Alert | Chaoju Eye Care Drops Over 7% After Interim Net Profit Declines 16.65%

HUTCHMED Sees Positive High Level Results in Lung Cancer Drug Combo Trial

MT Newswires Live

Hutchmed (China) - Announces Positive Results from Sanovo China Phase Trial in Nsclc Patients

THOMSON REUTERS

Hutchmed Announces Sanovo Trial Demonstrated Significant Progression-Free Survival Benefit of Orpathys® Plus Tagrisso® in Treatment-NaÏVe Patients with Met-Overexpressing Egfr-Mutated Lung Cancer in China

THOMSON REUTERS

Zhaoke Ophthalmology (SEHK:6622) Stock Carries A 34.7x P/S Under Heavy Losses

Simply Wall St.

The Fall of a Former Tea Industry Pioneer: From Market Darling to Penny Stock

Revenue Miss: MIXUE Group Fell 11% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Simply Wall St.

Here's Why UNQ Holdings (HKG:2177) Has Caught The Eye Of Investors

Simply Wall St.

Medlive Technology (SEHK:2192) Stock Holds Firm As Margin Strength Meets Growth Questions

Simply Wall St.

LING YUE SER GP Reports Interim Results: Net Profit Down 35.3% to RMB 34.3 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK1587/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":317.4844,"timestamp":1789114133774,"preClose":319.44687,"halted":0,"volume":104597924,"delay":0,"changeRate":-0.006143,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.962463,"latestTime":"09-11 16:00:00","open":319.42862,"high":319.88553,"low":313.59467,"amount":3559134410.4,"amplitude":0.019693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.339379,"peRate":15.260692,"turnoverRate":0.002002,"increases":12,"decrements":36,"flats":10,"marketCap":752353199316,"floatMarketCap":670179486148},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":319.88553,"amplitude":0.019693,"preClose":319.44687,"low":313.59467,"pbRate":"1.339379","latestPrice":317.4844,"volume":104597924,"delay":0,"open":319.42862,"prevYearClose":478.5753,"prevWeekClose":332.269,"prevMonthClose":342.657,"prevQuarterClose":326.657,"fiveDayClose":332.269,"twentyDayClose":346.279,"sixtyDayClose":361.102,"secType":"PLATE","market":"HK","turnoverRate":0.002002,"peRate":15.260692,"marketCap":752353199316,"floatMarketCap":670179486148,"timestamp":1789114133774,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":13,"down":34,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663761940","title":"BetterLife Holding H1 Revenue RMB 3,852.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663761940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663761940?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:16","pubTimestamp":1788167808,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nPLXGF9WPH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06909","BK1587","BK1239","BK1520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076152","title":"BetterLife Holding Ltd - Board Proposed not to Declare Any Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076152?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:16","pubTimestamp":1788167785,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R05A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1520","06909","BK1239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663761630","title":"BetterLife Turns to H1 FY26 Net Loss of RMB 107.3 Million; Revenue Rises 1% to RMB 3.85 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2663761630","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663761630?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:16","pubTimestamp":1788167762,"startTime":"0","endTime":"0","summary":"BetterLife turns to H1 FY26 net loss of RMB 107.3 million; revenue rises 1% to RMB 3.85 billionBetterLife posted a net loss of RMB 107.3 million, swinging from profit; basic loss per share was RMB 0.1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL3kYzGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1239","06909","BK1520","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663928076","title":"China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2663928076","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663928076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:14","pubTimestamp":1788167685,"startTime":"0","endTime":"0","summary":"China's HeartCare Medical H1 revenue surges on stroke segment growthOverviewChina medical device maker's H1 revenue rose 56.9% yr/yr to RMB291 mlnNet profit attributable to shareholders grew 18.5% yr/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S09G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0097","BK1191","01477","600085","BK0028","BK1587","06609","BK0239","BK0183","BK0012","BK1606","06622","BK1100","01666","BK1574","BK0196","LU1688375341.USD","BK1515","BK0113","BK1583","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663763580","title":"Shanghai HeartCare Medical Technology - Board Did not Declare the Payment of an Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663763580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663763580?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166975,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R07R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06609","BK1587","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076351","title":"Shanghai HeartCare H1 FY26 Profit Climbs 18.5% to RMB 60.37 Million; Revenue Rises 56.9% to RMB 291.03 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076351","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076351?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166937,"startTime":"0","endTime":"0","summary":"Shanghai HeartCare H1 FY26 profit climbs 18.5% to RMB 60.37 million; revenue rises 56.9% to RMB 291.03 millionShanghai HeartCare posted revenue of RMB 291.03 million, up 56.9% year over year; profit a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL636RtR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076331","title":"Shanghai HeartCare Medical Technology H1 Revenue RMB 291 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076331?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166936,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nPLXBXPQPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1587","BK1574","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075066","title":"Hong Kong Stocks Edge Lower on Monday Amid Middle East Tensions; HUTCHMED Falls 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075066?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:59","pubTimestamp":1788166745,"startTime":"0","endTime":"0","summary":"Hong Kong stocks closed slightly lower on Monday as renewed U.S.-Iran fighting pushed oil prices higher and added to concerns over inflation and interest rates.The Hang Seng Index fell 17.80 points, o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["07500","03115","HCM","HSI","BK1588","BK1191","BK1587","513600","HHImain","82800","02800","MHImain","03419","07300","HSTECH","03037","83115","07200","02833","00013","09115","MCHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663020106","title":"Hutchmed Says Savolitinib Plus AstraZeneca’s Tagrisso Extends PFS in China Phase III Sanovo Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663020106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663020106?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:15","pubTimestamp":1788160521,"startTime":"0","endTime":"0","summary":"HUTCHMED says savolitinib plus AstraZeneca’s Tagrisso extends PFS in China Phase III SANOVO lung cancer trialHUTCHMED reported positive high-level results from the SANOVO China Phase III trial in firs","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL8xkCdp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BQXX3F31.USD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","BK1191","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU2210150020.SGD","NDAQ","SG9999014005.SGD","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4588","BK4112","SG9999014021.USD","IE00BN0W2W23.USD","BK1588","BK1587","00013","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140895782","title":"Rebuilding Foundations: How KANGQIAO SER Charts a Quality-Driven Path in a Shifting Property Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1140895782","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140895782?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:04","pubTimestamp":1788159865,"startTime":"0","endTime":"0","summary":"As the real estate sector navigates its most profound adjustment in years, the investment narrative for Hong Kong-listed property management firms has undergone a complete transformation. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1258","BK1542","BK1229","BK1587","02205"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114884883","title":"Hong Kong Stock Alert | Chaoju Eye Care Drops Over 7% After Interim Net Profit Declines 16.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114884883","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114884883?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:42","pubTimestamp":1788158547,"startTime":"0","endTime":"0","summary":"Shares of Chaoju Eye Care (02219) fell more than 7% in Hong Kong trading, with the stock last down 7.28% at HK$2.355, on turnover of HK$4.907 million.According to the company's interim results for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","VXUS","BK4585","02219","KCAI","BK4588","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663579022","title":"HUTCHMED Sees Positive High Level Results in Lung Cancer Drug Combo Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663579022","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663579022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:39","pubTimestamp":1788154752,"startTime":"0","endTime":"0","summary":"HUTCHMED   announced positive high-level results from its SANOVO China phase  trial in treatment-nave patients with non-small cell lung cancer, according to a Monday Hong Kong bourse filing.ORPATHYS plus TAGRSSO significantly improved progression-free survival versus TAGRSSO alone in both high MET and intention-to-treat patient populations.The combination also showed an encouraging clinical benefit in overall survival in both populations, which was a secondary endpoint of the trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1587","BK1588","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028693","title":"Hutchmed (China) - Announces Positive Results from Sanovo China Phase Trial in Nsclc Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663028693?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:00","pubTimestamp":1788134458,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1588","00013","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663695028","title":"Hutchmed Announces Sanovo Trial Demonstrated Significant Progression-Free Survival Benefit of Orpathys® Plus Tagrisso® in Treatment-NaÏVe Patients with Met-Overexpressing Egfr-Mutated Lung Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2663695028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663695028?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:00","pubTimestamp":1788134402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA57F9PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00013","BK1588","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663266430","title":"Zhaoke Ophthalmology (SEHK:6622) Stock Carries A 34.7x P/S Under Heavy Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2663266430","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663266430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:36","pubTimestamp":1788129366,"startTime":"0","endTime":"0","summary":"Traders kept Zhaoke Ophthalmology almost flat coming into the H1 2026 report, with the stock up only about 2% over the past week. The calm price action contrasts with a much more charged reality. The company is still posting heavy losses, with H1 basic earnings per share at a loss of ¥0.22 and a net loss of ¥122.6 million.\nThe key issue is valuation. Zhaoke Ophthalmology trades on a P/S multiple of 34.7x, compared with the Hong Kong pharmaceuticals average near 2x. This puts every line of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6622/zhaoke-ophthalmology-shares/news/zhaoke-ophthalmology-sehk6622-stock-carries-a-347x-ps-under","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6622/zhaoke-ophthalmology-shares/news/zhaoke-ophthalmology-sehk6622-stock-carries-a-347x-ps-under","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1587","06622","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109313631","title":"The Fall of a Former Tea Industry Pioneer: From Market Darling to Penny Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1109313631","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109313631?lang=en_us&edition=fundamental","pubTime":"2026-08-30 12:20","pubTimestamp":1788063638,"startTime":"0","endTime":"0","summary":"At a franchisee conference held in southwest China in July 2026, the management of NAYUKI (HK: 02150) spent nearly an hour presenting a new compact store model designed to shrink floor space to as...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1616","02150","BK1587","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045337","title":"Revenue Miss: MIXUE Group Fell 11% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045337","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663045337?lang=en_us&edition=fundamental","pubTime":"2026-08-30 09:00","pubTimestamp":1788051612,"startTime":"0","endTime":"0","summary":"MIXUE Group ( HKG:2097 ) shareholders are probably feeling a little disappointed, since its shares fell 9.0% to HK$212...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2097/mixue-group-shares/news/revenue-miss-mixue-group-fell-11-short-of-analyst-revenue-es","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2097/mixue-group-shares/news/revenue-miss-mixue-group-fell-11-short-of-analyst-revenue-es","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02097","BK1616","JOYT","PMDE","VOTE","DECU","BK1587","GXDW","VGFPF","RGLO","FEBU","BK1233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045364","title":"Here's Why UNQ Holdings (HKG:2177) Has Caught The Eye Of Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045364","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663045364?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:39","pubTimestamp":1788050345,"startTime":"0","endTime":"0","summary":"For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice2-main-header/1585186866479","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice2-main-header/1585186866479"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/retail/hkg-2177/unq-holdings-shares/news/heres-why-unq-holdings-hkg2177-has-caught-the-eye-of-investo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/retail/hkg-2177/unq-holdings-shares/news/heres-why-unq-holdings-hkg2177-has-caught-the-eye-of-investo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1587","BK1142","BK4211","ISBC","EBIT","BK1224","02177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663453650","title":"Medlive Technology (SEHK:2192) Stock Holds Firm As Margin Strength Meets Growth Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663453650","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663453650?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:27","pubTimestamp":1788049647,"startTime":"0","endTime":"0","summary":"Medlive Technology went into this earnings print with a growth story and a valuation that screens cheaper than many Asian healthcare services peers. The stock closed at HK$7.67 on the day of the release after a flat to slightly soft week, even as the latest half year numbers kept profit quality in focus. The headline is simple. Revenue reached ¥315.2m in the first half of 2026 and basic earnings per share came in at ¥0.2187. That keeps Medlive firmly profitable while investors weigh what the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2192/medlive-technology-shares/news/medlive-technology-sehk2192-stock-holds-firm-as-margin-stren","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2192/medlive-technology-shares/news/medlive-technology-sehk2192-stock-holds-firm-as-margin-stren","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1189","LU0049112450.USD","LU1235295612.USD","BK1587","LU1046422090.SGD","02192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122872312","title":"LING YUE SER GP Reports Interim Results: Net Profit Down 35.3% to RMB 34.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1122872312","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122872312?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:42","pubTimestamp":1787935336,"startTime":"0","endTime":"0","summary":"LING YUE SER GP (02165) has announced its financial results for the six months ended June 30, 2026, revealing a decline in both revenue and profit during the period.The group recorded revenue of RMB...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1229","BK1587","02165","BK1542","BK1258"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":12,"totalSize":267,"code":"91000000","status":"200"}]}}